Enabling Molecularly Informed Cancer Medicine, National Cancer Institute
|
Presented by:
Richard Aragon, Ph.D., Director, IMAT Program, National Cancer Institute, and Anthony Dickherber, Ph.D., Office of the Director, National Cancer Institute
Overview: In 1998, the National Cancer Institute established the groundwork for a highly successful program focused on innovative technology development to meet the specific needs of the cancer community by stimulating the next generation of cross-cutting technologies capable of catalyzing progress in the understanding of the molecular and cellular basis of cancer. Unlike other initiatives of the time, IMAT solicited only the most cutting-edge ideas despite their potential risk, thus restricting its application pool to those projects that were risky but that also had the potential to be truly transformative, if successful.
|
|
